Banco Bilbao Vizcaya Argentaria S.A. purchased a new position in shares of Ceridian HCM Holding Inc. (NYSE:CDAY – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,369 shares of the company’s stock, valued at approximately $216,000.
Several other hedge funds and other institutional investors have also modified their holdings of CDAY. Lazard Asset Management LLC purchased a new position in shares of Ceridian HCM during the third quarter worth $25,000. Belpointe Asset Management LLC purchased a new position in shares of Ceridian HCM during the fourth quarter worth $35,000. Advisors Asset Management Inc. purchased a new position in shares of Ceridian HCM during the first quarter worth $41,000. Quadrant Capital Group LLC boosted its position in shares of Ceridian HCM by 40.7% during the fourth quarter. Quadrant Capital Group LLC now owns 781 shares of the company’s stock worth $50,000 after buying an additional 226 shares during the period. Finally, Parallel Advisors LLC boosted its position in shares of Ceridian HCM by 55.6% during the fourth quarter. Parallel Advisors LLC now owns 896 shares of the company’s stock worth $57,000 after buying an additional 320 shares during the period.
Wall Street Analyst Weigh In
CDAY has been the subject of several research analyst reports. Wells Fargo & Company lowered their price target on Ceridian HCM from $75.00 to $65.00 in a research report on Thursday, May 4th. Deutsche Bank Aktiengesellschaft lifted their target price on Ceridian HCM from $82.00 to $90.00 in a report on Thursday, February 9th. TheStreet upgraded Ceridian HCM from a “d+” rating to a “c-” rating in a report on Friday, February 10th. Robert W. Baird lifted their target price on Ceridian HCM from $78.00 to $86.00 and gave the company an “outperform” rating in a report on Friday, February 10th. Finally, Cowen lifted their target price on Ceridian HCM from $77.00 to $87.00 and gave the company an “outperform” rating in a report on Thursday, February 9th. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, Ceridian HCM currently has an average rating of “Moderate Buy” and a consensus target price of $78.79.
Insider Transactions at Ceridian HCM
Ceridian HCM Stock Up 4.0 %
CDAY opened at $64.91 on Monday. The business’s 50-day simple moving average is $64.50 and its 200-day simple moving average is $67.34. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.07 and a current ratio of 1.07. Ceridian HCM Holding Inc. has a one year low of $43.23 and a one year high of $79.66. The stock has a market capitalization of $9.94 billion, a P/E ratio of -270.46 and a beta of 1.44.
Ceridian HCM (NYSE:CDAY – Get Rating) last posted its earnings results on Wednesday, May 3rd. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.05). Ceridian HCM had a negative return on equity of 0.02% and a negative net margin of 2.73%. The firm had revenue of $370.60 million for the quarter, compared to analyst estimates of $360.77 million. Analysts anticipate that Ceridian HCM Holding Inc. will post 0.35 EPS for the current year.
About Ceridian HCM
Ceridian HCM Holding, Inc engages in the development of human capital management software. It offers Dayforce, Powerpay, and Bureau products and services. The Dayforce provides human resources (HR), payroll, benefits, workforce management, and talent management functionality. Powerpay is a cloud HR and payroll solution for the Canadian small business market, through both direct sales and established partner channels.
Read More
- Get a free copy of the StockNews.com research report on Ceridian HCM (CDAY)
- Will Nvidia Be the Lifeline Intel Desperately Needs?
- Is Li Auto Head and Shoulders Above Its Chinese Counterparts?
- MarketBeat Week in Review – 5/29 – 6/2
- Trading Channel Breakout in Lululemon Brought by Earnings
- What Should Investors Make of These 3 Dividend Cuts?
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.